MIRA Pharmaceuticals Statistics Share Statistics MIRA Pharmaceuticals has 17.39M
shares outstanding. The number of shares has increased by 17.62%
in one year.
Shares Outstanding 17.39M Shares Change (YoY) 17.62% Shares Change (QoQ) 4.98% Owned by Institutions (%) 5.82% Shares Floating 12.9M Failed to Deliver (FTD) Shares 9,526 FTD / Avg. Volume 0.7%
Short Selling Information The latest short interest is 1.2M, so 6.49% of the outstanding
shares have been sold short.
Short Interest 1.2M Short % of Shares Out 6.49% Short % of Float 8.2% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -2.24 and the forward
PE ratio is -4.2.
MIRA Pharmaceuticals's PEG ratio is
0.1.
PE Ratio -2.24 Forward PE -4.2 PS Ratio 0 Forward PS 0.1 PB Ratio 8 P/FCF Ratio -3.17 PEG Ratio 0.1
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for MIRA Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.99,
with a Debt / Equity ratio of 0.
Current Ratio 3.99 Quick Ratio 3.99 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage -48.4
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-3.93M Employee Count 2 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -32.7% in the
last 52 weeks. The beta is 1.79, so MIRA Pharmaceuticals's
price volatility has been higher than the market average.
Beta 1.79 52-Week Price Change -32.7% 50-Day Moving Average 1.42 200-Day Moving Average 1.25 Relative Strength Index (RSI) 41.51 Average Volume (20 Days) 1,352,924
Income Statement
Revenue n/a Gross Profit n/a Operating Income -8.02M Net Income -7.85M EBITDA -7.85M EBIT -7.69M Earnings Per Share (EPS) -0.51
Full Income Statement Balance Sheet The company has 2.83M in cash and 0 in
debt, giving a net cash position of 2.83M.
Cash & Cash Equivalents 2.83M Total Debt n/a Net Cash n/a Retained Earnings -29.14M Total Assets 1.4M Working Capital 1.26M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -5.56M
and capital expenditures 0, giving a free cash flow of -5.56M.
Operating Cash Flow -5.56M Capital Expenditures n/a Free Cash Flow -5.56M FCF Per Share -0.36
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
